Quadrature Capital Ltd Acquires 122,931 Shares of UiPath Inc. (NYSE:PATH)

Quadrature Capital Ltd raised its holdings in UiPath Inc. (NYSE:PATH - Free Report) by 94.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 253,112 shares of the healthcare company's stock after acquiring an additional 122,931 shares during the quarter. Quadrature Capital Ltd's holdings in UiPath were worth $6,289,000 as of its most recent SEC filing.

• GitLab’s Weak Results Were Priced In; Time to Buy the Dip?

Several other large investors have also recently modified their holdings of PATH. Mark Sheptoff Financial Planning LLC acquired a new position in shares of UiPath in the 4th quarter worth approximately $25,000. HighMark Wealth Management LLC acquired a new stake in UiPath during the 4th quarter worth about $27,000. Cypress Capital Management LLC WY bought a new position in shares of UiPath in the 4th quarter worth about $29,000. GAMMA Investing LLC acquired a new position in shares of UiPath in the 4th quarter valued at about $36,000. Finally, FNY Investment Advisers LLC acquired a new position in shares of UiPath in the 4th quarter valued at about $40,000. Institutional investors own 62.50% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. Scotiabank lowered their target price on UiPath from $30.00 to $25.00 and set a "sector perform" rating for the company in a report on Wednesday, May 29th. KeyCorp reiterated a "sector weight" rating on shares of UiPath in a research note on Thursday, May 30th. William Blair downgraded shares of UiPath from an "outperform" rating to a "market perform" rating in a research report on Thursday, May 30th. Royal Bank of Canada restated a "sector perform" rating and issued a $29.00 price target on shares of UiPath in a report on Monday, April 1st. Finally, Barclays lowered their target price on UiPath from $25.00 to $16.00 and set an "equal weight" rating on the stock in a research report on Thursday, May 30th. Sixteen research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, UiPath has a consensus rating of "Hold" and a consensus price target of $18.12.

• C3.ai is Starting to Show AI Tailwinds Accelerating

Get Our Latest Stock Report on PATH

Insider Transactions at UiPath

In other UiPath news, CFO Ashim Gupta sold 40,000 shares of the stock in a transaction that occurred on Thursday, April 4th. The shares were sold at an average price of $21.66, for a total transaction of $866,400.00. Following the transaction, the chief financial officer now directly owns 660,762 shares in the company, valued at $14,312,104.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In the last three months, insiders sold 96,000 shares of company stock worth $2,023,440. 22.37% of the stock is currently owned by corporate insiders.

UiPath Trading Down 2.0 %

• AI Is Booming, But Not For These Stocks …Yet

Shares of UiPath stock traded down $0.25 during trading on Friday, hitting $12.00. The stock had a trading volume of 13,496,576 shares, compared to its average volume of 15,195,349. UiPath Inc. has a 12 month low of $11.53 and a 12 month high of $27.87. The firm has a market cap of $6.83 billion, a price-to-earnings ratio of -75.00 and a beta of 0.85. The business's 50-day moving average is $18.84 and its 200 day moving average is $21.81.

UiPath (NYSE:PATH - Get Free Report) last posted its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.10. UiPath had a negative net margin of 6.41% and a negative return on equity of 2.97%. The company had revenue of $405.25 million for the quarter, compared to analysts' expectations of $383.32 million. As a group, equities analysts expect that UiPath Inc. will post -0.2 EPS for the current year.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Stories

• Five stocks we like better than UiPath
• Most Volatile Stocks, What Investors Need to Know
• MarketBeat Week in Review – 6/3 - 6/7
• What are earnings reports?
• Geron Corporation: FDA Approval Fuels Stock Price Surge
• Best Stocks Under $10.00
• Intel's Secret Plan for a Double-Digit Stock Rally Revealed

Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath Inc. (NYSE:PATH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ Breaking - The US Gov. Seized CITGO (From Augury Research) (Ad)

Should you invest $1,000 in UiPath right now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here